
Brian E. Mcdowell
Examiner (ID: 17098, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1657 |
| Issued Applications | 1038 |
| Pending Applications | 129 |
| Abandoned Applications | 533 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5458730
[patent_doc_number] => 20090258882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => '2,4-Substituted Quinazolines as Lipid Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/375450
[patent_app_country] => US
[patent_app_date] => 2007-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32461
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258882.pdf
[firstpage_image] =>[orig_patent_app_number] => 12375450
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/375450 | 2,4-Substituted Quinazolines as Lipid Kinase Inhibitors | Jul 24, 2007 | Abandoned |
Array
(
[id] => 7811381
[patent_doc_number] => 08133912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Methyl aquocobyrinic acid derivative, alkylation composition, and method for detoxifying a harmful compound by utilizing the composition'
[patent_app_type] => utility
[patent_app_number] => 12/309511
[patent_app_country] => US
[patent_app_date] => 2007-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 25
[patent_no_of_words] => 11313
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133912.pdf
[firstpage_image] =>[orig_patent_app_number] => 12309511
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/309511 | Methyl aquocobyrinic acid derivative, alkylation composition, and method for detoxifying a harmful compound by utilizing the composition | Jul 23, 2007 | Issued |
Array
(
[id] => 5490872
[patent_doc_number] => 20090291943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/373194
[patent_app_country] => US
[patent_app_date] => 2007-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5079
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291943.pdf
[firstpage_image] =>[orig_patent_app_number] => 12373194
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/373194 | Process for preparing diaminophenothiazinium compounds | Jul 11, 2007 | Issued |
Array
(
[id] => 5297362
[patent_doc_number] => 20090012288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Process for preparation of pentostatin (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz[4,5-d][1,3] diazepin-8-ol'
[patent_app_type] => utility
[patent_app_number] => 11/822177
[patent_app_country] => US
[patent_app_date] => 2007-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2323
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012288.pdf
[firstpage_image] =>[orig_patent_app_number] => 11822177
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/822177 | Process for preparation of pentostatin (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz[4,5-d][1,3] diazepin-8-ol | Jul 2, 2007 | Abandoned |
Array
(
[id] => 6545236
[patent_doc_number] => 20100016293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use'
[patent_app_type] => utility
[patent_app_number] => 12/307197
[patent_app_country] => US
[patent_app_date] => 2007-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11558
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016293.pdf
[firstpage_image] =>[orig_patent_app_number] => 12307197
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/307197 | Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use | Jul 2, 2007 | Abandoned |
Array
(
[id] => 6598841
[patent_doc_number] => 20100292229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'TRYPHOSTIN-ANALOGS FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/307088
[patent_app_country] => US
[patent_app_date] => 2007-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 28669
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292229.pdf
[firstpage_image] =>[orig_patent_app_number] => 12307088
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/307088 | TRYPHOSTIN-ANALOGS FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES | Jul 1, 2007 | Abandoned |
Array
(
[id] => 4910257
[patent_doc_number] => 20080021024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Metalloprotease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/824525
[patent_app_country] => US
[patent_app_date] => 2007-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26798
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20080021024.pdf
[firstpage_image] =>[orig_patent_app_number] => 11824525
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/824525 | Metalloprotease inhibitors | Jun 28, 2007 | Abandoned |
Array
(
[id] => 4910443
[patent_doc_number] => 20080021210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'COMPOSITIONS AND METHODS OF MAKING A PHOTOACTIVE AGENT'
[patent_app_type] => utility
[patent_app_number] => 11/772024
[patent_app_country] => US
[patent_app_date] => 2007-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6831
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20080021210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11772024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/772024 | Compositions and methods of making a photoactive agent | Jun 28, 2007 | Issued |
Array
(
[id] => 5279318
[patent_doc_number] => 20090131450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'USE OF PKC INHIBITORS IN DIABETIC COMPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/305249
[patent_app_country] => US
[patent_app_date] => 2007-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7004
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131450.pdf
[firstpage_image] =>[orig_patent_app_number] => 12305249
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305249 | USE OF PKC INHIBITORS IN DIABETIC COMPLICATIONS | Jun 27, 2007 | Abandoned |
Array
(
[id] => 4803608
[patent_doc_number] => 20080015197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Process for the preparatrion of zopiclone'
[patent_app_type] => utility
[patent_app_number] => 11/823345
[patent_app_country] => US
[patent_app_date] => 2007-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5085
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015197.pdf
[firstpage_image] =>[orig_patent_app_number] => 11823345
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/823345 | Process for the preparatrion of zopiclone | Jun 25, 2007 | Abandoned |
Array
(
[id] => 4853221
[patent_doc_number] => 20080318964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'DEUTERIUM-ENRICHED ESZOPICLONE'
[patent_app_type] => utility
[patent_app_number] => 11/765435
[patent_app_country] => US
[patent_app_date] => 2007-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4273
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318964.pdf
[firstpage_image] =>[orig_patent_app_number] => 11765435
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/765435 | DEUTERIUM-ENRICHED ESZOPICLONE | Jun 18, 2007 | Abandoned |
Array
(
[id] => 4658201
[patent_doc_number] => 20080027063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/758243
[patent_app_country] => US
[patent_app_date] => 2007-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25255
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20080027063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11758243
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/758243 | Imidazopyrazines as protein kinase inhibitors | Jun 4, 2007 | Issued |
Array
(
[id] => 5231401
[patent_doc_number] => 20070293509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Pyrazinecarboxamide derivatives as CB1 antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/809047
[patent_app_country] => US
[patent_app_date] => 2007-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21598
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293509.pdf
[firstpage_image] =>[orig_patent_app_number] => 11809047
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/809047 | Pyrazinecarboxamide derivatives as CB1 antagonists | May 29, 2007 | Issued |
Array
(
[id] => 4710689
[patent_doc_number] => 20080299215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'DEUTERIUM-ENRICHED LESTAURTINIB'
[patent_app_type] => utility
[patent_app_number] => 11/754390
[patent_app_country] => US
[patent_app_date] => 2007-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3718
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299215.pdf
[firstpage_image] =>[orig_patent_app_number] => 11754390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/754390 | DEUTERIUM-ENRICHED LESTAURTINIB | May 28, 2007 | Abandoned |
Array
(
[id] => 285538
[patent_doc_number] => 07550465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them'
[patent_app_type] => utility
[patent_app_number] => 11/753207
[patent_app_country] => US
[patent_app_date] => 2007-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 8
[patent_no_of_words] => 16229
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550465.pdf
[firstpage_image] =>[orig_patent_app_number] => 11753207
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/753207 | Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them | May 23, 2007 | Issued |
Array
(
[id] => 4910277
[patent_doc_number] => 20080021044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'N-[2-[[(DIAMINOMETHYLENE)AMINO]OXY]ETHYL]-3-[(2,2-DIFLUORO-2-PHENYLETHYL)AMINO]-6-METHYL-2-OXO-1(2H)-PYRAZINEACETAMIDE'
[patent_app_type] => utility
[patent_app_number] => 11/751155
[patent_app_country] => US
[patent_app_date] => 2007-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15777
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20080021044.pdf
[firstpage_image] =>[orig_patent_app_number] => 11751155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/751155 | N-[2-[[(DIAMINOMETHYLENE)AMINO]OXY]ETHYL]-3-[(2,2-DIFLUORO-2-PHENYLETHYL)AMINO]-6-METHYL-2-OXO-1(2H)-PYRAZINEACETAMIDE | May 20, 2007 | Abandoned |
Array
(
[id] => 4670421
[patent_doc_number] => 20080045481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'NOVEL CO-CRYSTAL'
[patent_app_type] => utility
[patent_app_number] => 11/748651
[patent_app_country] => US
[patent_app_date] => 2007-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15287
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045481.pdf
[firstpage_image] =>[orig_patent_app_number] => 11748651
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/748651 | Co-crystal | May 14, 2007 | Issued |
Array
(
[id] => 4509070
[patent_doc_number] => 07915409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-29
[patent_title] => 'Organometal complex and light-emitting element using the same'
[patent_app_type] => utility
[patent_app_number] => 11/797532
[patent_app_country] => US
[patent_app_date] => 2007-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 10795
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/915/07915409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11797532
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/797532 | Organometal complex and light-emitting element using the same | May 3, 2007 | Issued |
Array
(
[id] => 228903
[patent_doc_number] => 07601716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-13
[patent_title] => 'Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/799066
[patent_app_country] => US
[patent_app_date] => 2007-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84793
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/601/07601716.pdf
[firstpage_image] =>[orig_patent_app_number] => 11799066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/799066 | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors | Apr 29, 2007 | Issued |
Array
(
[id] => 8896737
[patent_doc_number] => 08476258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same'
[patent_app_type] => utility
[patent_app_number] => 12/298564
[patent_app_country] => US
[patent_app_date] => 2007-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5069
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12298564
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298564 | Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same | Apr 25, 2007 | Issued |